Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (17)

2023

  1. A Biomathematical Model of Tumor Response to Radioimmunotherapy with αpDL1 and αcTLA4

    IEEE/ACM Transactions on Computational Biology and Bioinformatics, Vol. 20, Núm. 2, pp. 808-821

  2. Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

    JNCI Cancer Spectrum, Vol. 7, Núm. 6

  3. Radiobiological Meta-Analysis of the Response of Prostate Cancer to Different Fractionations: Evaluation of the Linear–Quadratic Response at Large Doses and the Effect of Risk and ADT

    Cancers, Vol. 15, Núm. 14

  4. Variation of the relative biological effectiveness with fractionation in proton therapy: Analysis of prostate cancer response

    Medical Physics, Vol. 50, Núm. 11, pp. 7304-7312

2019

  1. A model of indirect cell death caused by tumor vascular damage after high-dose radiotherapy

    Cancer Research, Vol. 79, Núm. 23, pp. 6044-6053

  2. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1)

    Nature Communications

2018

  1. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

    Nature Communications, Vol. 9, Núm. 1

  2. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

    Nature Communications, Vol. 9, Núm. 1

  3. Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC– Ain't no mountain high enough…. to keep me getting to you

    Lung Cancer

2016

  1. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]

    Reports of Practical Oncology and Radiotherapy

  2. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer

    EBioMedicine, Vol. 10, pp. 150-163

2015

  1. Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies

    Clinical and Translational Oncology, Vol. 17, Núm. 3, pp. 223-229

  2. Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance

    Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 4, pp. 259-272

2014

  1. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

    Nature Genetics, Vol. 46, Núm. 8, pp. 891-894

  2. Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity

    Radiotherapy and Oncology, Vol. 111, Núm. 2, pp. 199-205

2010

  1. Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: High incidence of somatic mutations and their relation with response

    Pharmacogenomics, Vol. 11, Núm. 6, pp. 747-761

  2. Spanish radiobiological pattern of care in lung cancer: A GOECP/SEOR study

    Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 292-298